Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome

Archives of Dermatological Research

Volumn 306, Issue 3, 2014, Pages 239-245

  El Hadidi, H ^a   Samir, N ^a,b   Shaker, O G ^a   Otb, S ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Department of Biochemistry and Molecular Biology Faculty of Medicine Cairo University ^*  (Egypt)

Author keywords

Lipocalin 2; Metabolic syndrome; Psoriasis

Indexed keywords

C REACTIVE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPIDS; LIPOCALINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84898654692     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1414-x     Document Type: Article

References (18)

1. Alberti KG, Robert H, Eckel MD et al (2009) "Harmonizing the metabolic syndrome": a joint interim statement of the international diabetes federation task force on epidemiology and prevention national Heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640-1645
2. Chooi KM, Lee JS, Kim EJ et al (2008) Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 158:203-207
3. Corral R, Montori A, Victor M et al (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368(9536):666-678
4. Flisiak I, Chodynicka B, Porebski P et al (2002) Association between psoriasis severity and transforming growth factor beta 1 and beta 2 in plasma and scales from psoriatic lesions. Cytokine 19:121-125
5. Flo TH, Smith KD, Sato S et al (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921
6. Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A-11A
7. Jang Y, Lee HJ, Wang Y, Sweeney G (2012) Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. Clin Exp Pharmacol Physiol 39:194-199
8. Kamata M, Tada Y, Tatsuta A et al (2012) Serum lipocalin-2 levels are increased in patients with psoriasis. Clin Exp Dermatol 37:296-299
9. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425-10432
10. Langan SM, Seminara NM, Shin DB et al (2012) Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the UK. J Inv Dermatol 132:556-562
11. Mallbris L, O'Brien KP, Hulthén A et al (2002) Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp Dermatol 11:584-591
12. Mebazaa A, El Asmi M, Zidi W et al (2011) Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol 25:705-709
13. Moreno-Navarrete JM, Manco M, Ibanez J et al (2010) Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes 34:240-249
14. Romaní J, Caixàs A, Ceperuelo-Mallafré V et al (2012) Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. Arch Dermatol Res 305:105-112
15. Seo SJ, Ahn JY, Hong CK et al (2006) Expression of neutrophil gelatinase-associated lipocalin in skin epidermis. J Inv Dermatol 126:510-512
16. Stejskal D, Karpisek M, Humenanska V et al (2008) Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res 40:381-385
17. Sterry W, Strober BE, Menter A (2007) Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 157:649-655
18. Wang Y, Lam KS, Kraegen EW et al (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53:34-41